This company develops novel genomic technologies to provide deep insights into tumor biology, evolution, and treatment response. They utilize ultra-deep sequencing of cell-free DNA and comprehensive epigenetic profiling to generate high-resolution data. A proprietary AI/ML platform analyzes this data for advanced biomarker discovery and monitoring of disease progression.
Funding
Funding not disclosed
Founders
Product
Problem
Identifying novel therapeutic targets and reliable biomarkers for cancer treatment is a complex process hindered by the sheer volume and intricacy of genomic data. This complexity often leads to protracted drug discovery timelines and suboptimal patient outcomes due to a lack of precise molecular insights.
Solution
NoRD Bio employs advanced computational biology and artificial intelligence to analyze large-scale genomic datasets, enabling the identification of novel therapeutic targets and predictive biomarkers for oncology. The platform's proprietary algorithms process multi-omics data to uncover actionable insights into tumor biology and treatment response. By integrating these computational analyses, NoRD Bio aims to significantly accelerate the preclinical drug discovery pipeline and enhance the precision of cancer therapies. This approach facilitates the development of more effective treatments by pinpointing specific molecular pathways and patient subgroups most likely to benefit.
Target Audience
The primary customers are pharmaceutical and biotechnology companies engaged in oncology drug discovery and development, as well as academic research institutions focused on cancer genomics.
Features
- AI-driven genomic data analysis pipeline for identifying novel oncology targets
- Multi-omics data integration capabilities to provide a comprehensive view of tumor biology
- Machine learning models for biomarker discovery and patient stratification
- Computational platform designed to accelerate preclinical drug discovery workflows
- Analysis of genomic alterations, gene expression, and epigenetic modifications